Conference - London, United Kingdom
The diagnosis and management of heart failure remains challenging despite many advances in recent decades. With a greater understanding of this complex syndrome, a large number of candidate biomarkers have emerged which could serve as an indicator of the presence, severity and possible therapeutic response of the heart failure syndrome. This event will look at the current research assessing the the use of biomarkers for detection and prognosis of heart failure.
- Organization: Euroscicon
- Using Biomarkers to Predict Heart Failure and for Disease Management
Wed, Nov 05, 2014 - Wed, Nov 05, 2014 (9:00am - 5:00pm)
Cineworld: The O2
Peninsula Square, London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
